上皮性卵巢癌中长链非编码RNA的基因芯片表达谱分析
Microarray expression profiling of long non-coding RNAs in epithelial ovarian cancer.
作者信息
Ding Ye, Yang Da-Zheng, Zhai Yong-Ning, Xue Kai, Xu Feng, Gu Xiao-Yan, Wang Su-Min
机构信息
State Key Laboratory of Reproductive Medicine, Department of Endoscopic Diagnostic and Treatment Center, Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu 210004, P.R. China.
出版信息
Oncol Lett. 2017 Aug;14(2):2523-2530. doi: 10.3892/ol.2017.6448. Epub 2017 Jun 21.
Although numerous long non-coding RNAs (lncRNAs) have been identified to be important in human cancer, their potential regulatory roles in epithelial tumorigenesis and tumor progression in ovarian cancer remain unclear. The purpose of the present study was to investigate lncRNAs that were differentially expressed (DE) in epithelial ovarian cancer and to explore their potential functions. The lncRNA profiles in five pairs of human epithelial ovarian cancer tissues and their adjacent normal tissues were described using microarrays. The results of the microarray analysis revealed that 672 upregulated and 549 downregulated (fold-change ≥2.0) lncRNAs were DE between the cancerous and normal tissues. Reverse transcription-quantitative polymerase chain reaction was used to validate the microarray results using four upregulated (RP11-1C1.7, XLOC_003286, growth arrest-specific 5 and ZNF295-AS1) and four downregulated (protein tyrosine kinase 7, maternally expressed gene 3, AC079776.2 and ribosomal protein lateral stalk subunit P0 pseudogene 2) lncRNAs. Furthermore, gene ontology and pathway analyses were used to carry out functional analyses of the candidate genes of DE lncRNAs. The results identified lncRNAs with significantly altered expression profiles in human epithelial ovarian cancer cells compared with those in adjacent normal cells. These data offer new insights into the occurrence and development of epithelial ovarian cancer, and these lncRNAs may provide novel molecular biomarkers for further research on epithelial ovarian cancer.
尽管已鉴定出众多长链非编码RNA(lncRNA)在人类癌症中具有重要作用,但其在卵巢癌上皮肿瘤发生和肿瘤进展中的潜在调控作用仍不清楚。本研究的目的是调查上皮性卵巢癌中差异表达(DE)的lncRNA,并探索其潜在功能。使用微阵列描述了五对人上皮性卵巢癌组织及其相邻正常组织中的lncRNA谱。微阵列分析结果显示,癌组织与正常组织之间有672个lncRNA上调,549个lncRNA下调(倍数变化≥2.0)。使用逆转录定量聚合酶链反应,利用四个上调的lncRNA(RP11-1C1.7、XLOC_003286、生长停滞特异性5和ZNF295-AS1)和四个下调的lncRNA(蛋白酪氨酸激酶7、母源表达基因3、AC079776.2和核糖体蛋白侧柄亚基P0假基因2)验证微阵列结果。此外,利用基因本体论和通路分析对DE lncRNA的候选基因进行功能分析。结果确定了与相邻正常细胞相比,人上皮性卵巢癌细胞中表达谱有显著改变的lncRNA。这些数据为上皮性卵巢癌的发生和发展提供了新的见解,这些lncRNA可能为上皮性卵巢癌的进一步研究提供新的分子生物标志物。